amphetamine has been researched along with Anxiety Neuroses in 24 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the relationship between ATS use and mental disorders is complex, with divergent patterns of association for ecstasy and methamphetamine use." | 4.02 | The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not. ( Najman, JM; Pourmarzi, D; Smirnov, A; Thoradeniya, MR; Wessel, EL, 2021) |
| "Amphetamine treatment increased CRF(2) receptor densities in most subregions of the dRN, and CRF(2) receptors were still elevated following 6 weeks of withdrawal." | 1.35 | Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus. ( Forster, GL; Lukkes, JL; Mouw, NJ; Pringle, RB, 2008) |
| " The present study was designed to examine the possible effects of chronic administration of quetiapine, an atypical antipsychotic drug, on the anxiety-like behavioural consequences of a neurotoxic regimen of dl-amphetamine." | 1.33 | Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats. ( He, J; Li, XM; Xu, H; Yang, Y; Zhang, X, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Thoradeniya, MR | 1 |
| Wessel, EL | 1 |
| Pourmarzi, D | 1 |
| Najman, JM | 1 |
| Smirnov, A | 1 |
| Lehner, M | 1 |
| Gryz, M | 2 |
| Wisłowska-Stanek, A | 2 |
| Turzyńska, D | 2 |
| Sobolewska, A | 2 |
| Skórzewska, A | 2 |
| Płaźnik, A | 2 |
| Suhaiban, H | 1 |
| Javanbakht, A | 1 |
| Ravenelle, R | 1 |
| Santolucito, HB | 1 |
| Byrnes, EM | 1 |
| Byrnes, JJ | 1 |
| Donaldson, ST | 1 |
| Lehner, MH | 1 |
| Taracha, E | 1 |
| Kaniuga, E | 1 |
| Pringle, RB | 1 |
| Mouw, NJ | 1 |
| Lukkes, JL | 1 |
| Forster, GL | 1 |
| Marcus, SC | 1 |
| Durkin, M | 1 |
| Kalinichev, M | 1 |
| Rouillier, M | 1 |
| Girard, F | 1 |
| Royer-Urios, I | 1 |
| Bournique, B | 1 |
| Finn, T | 1 |
| Charvin, D | 1 |
| Campo, B | 1 |
| Le Poul, E | 1 |
| Mutel, V | 1 |
| Poli, S | 1 |
| Neale, SA | 1 |
| Salt, TE | 1 |
| Lütjens, R | 1 |
| LANZETTA, JT | 1 |
| WENDT, GR | 1 |
| LANGHAM, P | 1 |
| HAEFNER, D | 1 |
| SCHOPBACH, RR | 1 |
| SETTEL, E | 1 |
| FEIGLEY, DM | 1 |
| BEECHER, HK | 1 |
| SMITH, GM | 1 |
| PFEIFFER, CC | 1 |
| GOLDSTEIN, L | 1 |
| WEITZNER, M | 1 |
| Janowsky, DS | 1 |
| Quinn, PO | 1 |
| He, J | 1 |
| Xu, H | 1 |
| Yang, Y | 1 |
| Zhang, X | 1 |
| Li, XM | 1 |
| Fukushima, A | 1 |
| de Wit, H | 1 |
| Uhlenhuth, EH | 1 |
| Hedeker, D | 1 |
| McCracken, SG | 1 |
| Johanson, CE | 1 |
| Koupernik, C | 1 |
| Marino, A | 1 |
| Prendergast, FG | 1 |
2 reviews available for amphetamine and Anxiety Neuroses
| Article | Year |
|---|---|
Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: effects of antidepressants, amphetamine, and methylphenidate.
Topics: Amphetamine; Antidepressive Agents; Anxiety Disorders; Central Nervous System Stimulants; Clinical T | 2003 |
Biogenic amines and psychiatry.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Amines; Amphetamine; Anxiety Disorders; Attention Deficit D | 1971 |
1 trial available for amphetamine and Anxiety Neuroses
| Article | Year |
|---|---|
Lack of preference for diazepam in anxious volunteers.
Topics: Adult; Amphetamine; Anxiety Disorders; Attitude to Health; Choice Behavior; Diazepam; Female; Humans | 1986 |
21 other studies available for amphetamine and Anxiety Neuroses
| Article | Year |
|---|---|
The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not.
Topics: Amphetamine; Anxiety Disorders; Australia; Depressive Disorder, Major; Humans; Mania; Mental Disorde | 2021 |
The amphetamine-associated context exerts a stronger motivational effect in low-anxiety rats than in high-anxiety rats.
Topics: Amphetamine; Amphetamines; Amygdala; Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Conditio | 2017 |
Resolution of Anxiety Symptoms in Response to Stimulants in a Patient With Attention-Deficit/Hyperactivity Disorder and Generalized Anxiety Disorder.
Topics: Adult; Amphetamine; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervou | 2018 |
Housing environment modulates physiological and behavioral responses to anxiogenic stimuli in trait anxiety male rats.
Topics: Amphetamine; Animals; Anxiety Disorders; Blood Pressure; Body Temperature; Brain; Brain-Derived Neur | 2014 |
Low-anxiety rats are more sensitive to amphetamine in comparison to high-anxiety rats.
Topics: Amphetamine; Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Conditioning, Classical; Conditi | 2017 |
Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus.
Topics: Adrenal Cortex Hormones; Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety Disorders; Cen | 2008 |
Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Topics: Achievement; Adolescent; Amphetamine; Anxiety Disorders; Attention Deficit and Disruptive Behavior D | 2011 |
ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterization.
Topics: Allosteric Regulation; Amphetamine; Animals; Anxiety Disorders; Behavior, Animal; Cell Line; Chromos | 2013 |
The effects of an anxiety-reducing medication on group behavior under threat.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Barbiturates; Behavior; Humans | 1956 |
Anxiety and its pharmacologic control.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Humans; Tranquilizing Agents | 1957 |
Dextro-amphetamine sulfate in mild depression and anxiety.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Dextroamphet | 1957 |
Office care of mild emotional distress.
Topics: Amobarbital; Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Atropa belladonna; Depression; D | 1962 |
THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. THE NEED FOR A QUANTITATIVE APPROACH TO THE STUDY OF "DEPRESSANT TRANQUILIZERS".
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Drug Therapy; Hypnotics and Sedatives; Morphi | 1964 |
PANEL DISCUSSION. 3. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. ASSAY OF ANTI-ANXIETY DRUGS BY QUANTITATIVE ELECTROENCEPHALOGRAPHY.
Topics: Alcohols; Amphetamine; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Biomedical Research; Chlordi | 1964 |
MANIFEST ANXIETY, AMPHETAMINE, AND PERFORMANCE.
Topics: Amphetamine; Amphetamines; Anxiety; Anxiety Disorders; Humans; Motor Skills; Paired-Associate Learni | 1965 |
Treating adolescent girls and women with ADHD: gender-specific issues.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Anxiety Disorders; Attention Deficit Disorder with Hype | 2005 |
Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Anxiety Disorders; Behavior, Anima | 2005 |
Criminal responsibility in amphetamine psychosis.
Topics: Adult; Amphetamine; Anxiety Disorders; Expert Testimony; Homicide; Humans; Insanity Defense; Liabili | 1994 |
Chemotherapy in child psychiatry.
Topics: Amphetamine; Anxiety Disorders; Child; Child Psychiatry; Child, Preschool; Chlordiazepoxide; Diazepa | 1972 |
Psychopharmacological approach to psychosomatic medicine. Experimental and clinical research.
Topics: Amitriptyline; Amphetamine; Animals; Anxiety Disorders; Benactyzine; Depression; Guinea Pigs; Hostil | 1967 |
The treatment of early anxiety, neurosis.
Topics: Adult; Amobarbital; Amphetamine; Anxiety Disorders; Chlordiazepoxide; Diazepam; Electroconvulsive Th | 1968 |